pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Sep 10·1 min read
save

CDMOs Redefine Pharma Supply Chains with AI, Cold-Chain Logistics and Smart Sourcing

Sep 10, 2026·read at BioSpace ↗Neutral

In a recent episode of BioSpace’s Denatured podcast, host Jennifer Smith-Parker talks with Arvind Singh, vice-president and global head of supply chain at SK Pharmteco. The discussion is presented in partnership with SK Pharmteco.

The conversation focuses on how contract development and manufacturing organisations are changing supply-chain strategies to support a new generation of complex modalities such as cell and gene therapies.

Key topics include smarter raw-material sourcing, precision cold-chain logistics, navigating geopolitical uncertainty, and using artificial intelligence to build sustainable and scalable clinical and commercial capabilities.

The guests note that the views expressed are their own and do not represent their companies.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “The supply chain fault lines of modern pharma”

read at BioSpace ↗
304 words · retrieved Sep 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
CRO/CDMOCell TherapyGene Therapy (AAV)

related stories

  • 3d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 5Swiss CDMOs and CROs ride a new wave of growth amid surge in global demandBioSpace
  • Sep 17Webinar: Manufacturing in Turbulent TimesBioSpace
  • Sep 3The hidden scale-out problem behind CAR-T’s growthBioPharma Dive
  • Aug 26Inside the Gulf biotech deal model, ahead of RGMBS 2026 in RiyadhBioSpace